Antiviral agents in Alzheimer-s disease: Hope for the future?

Therapeutic Advances in Neurological Disorders

Volumn 3, Issue 3, 2010, Pages 141-152

  Wozniak, Matthew A ^a   Itzhaki, Ruth F ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIVIRUS AGENT; APOLIPOPROTEIN E4; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN; PROTEIN KINASE R; TAU PROTEIN; VALACICLOVIR; VIRUS DNA;

ALZHEIMER DISEASE; ANTIVIRAL THERAPY; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN INFECTION; DISEASE ASSOCIATION; DRUG PENETRATION; DRUG TOLERABILITY; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENETIC PREDISPOSITION; GENETIC RISK; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HETEROZYGOSITY; HUMAN; IMMUNOCYTOCHEMISTRY; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RISK REDUCTION; SENILE PLAQUE; UNSPECIFIED SIDE EFFECT; VIRUS DETECTION; VIRUS LOAD; VIRUS REACTIVATION;

EID: 77953463815     PISSN: 17562856     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756285610370069     Document Type: Editorial

References (76)

1. Amsterdam, J.D., Maislin, G. and Hooper, M.B. ( 1996) Suppression of herpes simplex virus infections with oral lithium carbonate-a possible antiviral activity. Pharmacotherapy 16: 1070-1075.
2. Anthony, I.C., Ramage, S.N., Carnie, F.W., Simmonds, P. and Bell, J.E. ( 2006) Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol ( Berl) 111: 529-538.
3. Avila, J. and Hernandez, F. ( 2007) GSK-3 inhibitors for Alzheimer's disease. Expert Rev Neurother 7: 1527-1533.
4. Ball, M.J. ( 1982) Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved? Can J Neurol Sci 9: 303-306.
5. Bancher, C., Leitner, H., Jellinger, K., Eder, H., Setinek, U., Fischer, P. et al. (1996) On the relationship between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitis. Neurobiol Aging 17: 527-533.
6. Baringer, J.R. and Pisani, P. ( 1994) Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol 36: 823-829.
7. Beffert, U., Bertrand, P., Champagne, D., Gauthier, S. and Poirier, J. ( 1998) HSV-1 in brain and risk of Alzheimer's disease. Lancet 351: 1330-1331.
8. Bertrand, P., Guillaume, D., Hellauer, L., Dea, D., Lindsay, J., Kogan, S. et al. (1993) Distribution of herpes simplex virus type 1 DNA in selected areas of normal and Alzheimer's disease brains: a PCR study. Neurodegeneration 2: 201-208.
9. Bhattacharjee, P.S., Neumann, D.M., Foster, T.P., Bouhanik, S., Clement, C., Vinay, D. et al. (2008) Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1. Exp Eye Res 87: 122-130.
10. Bullido, M.J., Martinez-Garcia, A., Tenorio, R., Sastre, I., Munoz, D.G., Frank, A. et al. (2008) Double stranded RNA activated EIF 2 alpha kinase (EIF2AK2; PKR) is associated with Alzheimer's disease. Neurobiol Aging 29: 1160-1166.
11. Burgos, J.S., Ramirez, C., Sastre, I., Bullido, M.J. and Valdivieso, F. ( 2003) ApoE 4 is more efficient than E 3 in brain access by herpes simplex virus type 1. Neuroreport 14: 1825-1827.
12. Burgos, J.S., Ramirez, C., Sastre, I. and Valdivieso, F. ( 2006) Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA. J Virol 80: 5383-5387.
13. Carter, C.J. ( 2008) Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades. Neurochem Int 52: 920-934.
14. Corder, E.H., Robertson, K., Lannfelt, L., Bogdanovic, N., Eggertsen, G., Wilkins, J. et al. (1998) HIV-infected subjects with the E 4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 4: 1182-1184.
15. Cribbs, D.H., Azizeh, B.Y., Cotman, C.W. and LaFerla, F.M. ( 2000) Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A beta peptide. Biochemistry 39: 5988-5994.
16. Devi, G., Schultz, S., Khosrowshahi, L., Agnew, A. and Olali, E. ( 2008) A retrospective chart review of the tolerability and efficacy of intravenous immunoglobulin in the treatment of Alzheimer's disease. J Am Geriatr Soc 56: 772-774.
17. Dhingra, V., Li, Q., Allison, A.B., Stallknecht, D.E. and Fu, Z.F. ( 2005) Proteomic profiling and neurodegeneration in West-Nile-virus-infected neurons. J Biomed Biotechnol 2005: 271-279.
18. Erlich, K.S. and Mills, J. ( 1986) Passive immunotherapy for encephalitis caused by herpes simplex virus. Rev Infect Dis 8 Suppl 4: S439-S445.
19. Esiri, M.M., Biddolph, S.C. and Morris, C.S. ( 1998) Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 65: 29-33.
20. Esiri, M.M., Drummond, C.W. and Morris, C.S. ( 1995) Macrophages and microglia in HSV-1 infected mouse brain. J Neuroimmunol 62: 201-205.
21. Fillit, H., Hess, G., Hill, J., Bonnet, P. and Toso, C. (2009) IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders. Neurology 73: 180-185.
22. Friedman, J.E., Zabriskie, J.B., Plank, C., Ablashi, D., Whitman, J., Shahan, B. et al. (2005) A randomized clinical trial of valacyclovir in multiple sclerosis. Mult Scler 11: 286-295.
23. Ginsberg, S.D., Crino, P.B., Lee, V.M., Eberwine, J.H. and Trojanowski, J.Q. ( 1997) Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques. Ann Neurol 41: 200-209.
24. Gordon, L., McQuaid, S. and Cosby, S.L. ( 1996) Detection of herpes simplex virus types 1 and 2 and human herpes virus 6 DNA in human brain tissue by polymerase chain reaction. Clin Diagnost Virol 6: 33-40.
25. Gouin, J.P., Hantsoo, L. and Kiecolt-Glaser, J.K. ( 2008) Immune dysregulation and chronic stress among older adults: a review. Neuroimmunomodulation 15: 251-259.
26. Hemling, N., Roytta, M., Rinne, J., Pollanen, P., Broberg, E., Tapio, V. et al. (2003) Herpesviruses in brains in Alzheimer's and Parkinson's diseases. Ann Neurol 54: 267-271.
27. Hemling, N., Roytta, M., Rinne, J., Pollanen, P., Broberg, E., Tapio, V. et al. (2004) Herpes simplex virus type 1 and Alzheimer's disease. Ann Neurol 55: 300-301.
28. Hokkanen, L. and Launes, J. ( 2000) Cognitive outcome in acute sporadic encephalitis. Neuropsychol Rev 10: 151-167.
29. Holmes, C., El-Okl, M., Williams, A.L., Cunningham, C., Wilcockson, D. and Perry, V.H. ( 2003) Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 74: 788-789.
30. Itabashi, S., Arai, H., Matsui, T., Higuchi, S. and Sasaki, H. ( 1997) Herpes simplex virus and risk of Alzheimer's disease. Lancet 349: 1102.
31. Itzhaki, R.F., Dobson, C.B., Lin, W.R. and Wozniak, M.A. ( 2001) Association of HSV 1 and apolipoprotein E-varepsilon4 in Alzheimer's disease. J Neurovirol 7: 570-571.
32. Itzhaki, R.F., Lin, W.R., Shang, D., Wilcock, G.K., Faragher, B. and Jamieson, G.A. ( 1997a) Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349: 241-244.
33. Itzhaki, R.F., Lin, W.R., Shang, D., Wilcock, G.K., Faragher, B. and Jamieson, G.A. ( 1997b) Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349: 241-244.
34. Itzhaki, R.F. and Wozniak, M.A. ( 2008) Herpes simplex virus type 1 in Alzheimer's disease: the enemy within. J Alzheimers Dis 13: 393-405.
35. Itzhaki, R.F. and Wozniak, M.A. ( 2009) Apolipoprotein E: microbial friend or foe? In: Apoproteins: Research Trends, Nova Science Publications : New York.
36. Jamieson, G.A., Maitland, N.J., Wilcock, G.K., Craske, J. and Itzhaki, R.F. ( 1991) Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. J Med Virol 33: 224-227.
37. Jamieson, G.A., Maitland, N.J., Wilcock, G.K., Yates, C.M. and Itzhaki, R.F. ( 1992) Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J Pathol 167: 365-368.
38. Jayasuriya, A., Itzhaki, R., Wozniak, M., Patel, R., Smit, E., Noone, R. et al. (2008) Apolipoprotein{epsilon}4 and recurrent genital herpes in HSV type 2 and HIV co-infected individuals. Sex Transm Infect 84: 516-517.
39. Ji, Z.S., Brecht, W.J., Miranda, R.D., Hussain, M.M., Innerarity, T.L. and Mahley, R.W. ( 1993) Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem 268: 10160-10167.
40. Kim, D.Y., Ingano, L.A. and Kovacs, D.M. ( 2002) Nectin-1alpha, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/gamma-secretase-like cleavage. J Biol Chem 277: 49976-49981.
41. Klapper, P.E., Cleator, G.M. and Longson, M. ( 1984) Mild forms of herpes encephalitis. J Neurol Neurosurg Psychiatry 47: 1247-1250.
42. Kohl, S. and Loo, L.S. ( 1986) In vitro and in vivo antibody-dependent cellular cytotoxicity of intravenous immunoglobulin G preparations against herpes simplex virus. Rev Infect Dis 8 Suppl 4: S446-S448.
43. Letenneur, L., Peres, K., Fleury, H., Garrigue, I., Barberger-Gateau, P., Helmer, C. et al. (2008) Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PloS ONE 3: e3637.
44. Lin, W.R., Graham, J., MacGowan, S.M., Wilcock, G.K. and Itzhaki, R.F. ( 1998) Alzheimer's disease, herpes virus in brain, apolipoprotein E 4 and herpes labialis. Alzheimer's Rep 1: 173-178.
45. Lin, W.R., Wozniak, M.A., Esiri, M.M., Klenerman, P. and Itzhaki, R.F. ( 2001) Herpes simplex encephalitis: involvement of apolipoprotein E genotype. J Neurol Neurosurg Psychiatry 70: 117-119.
46. Little, C.S., Hammond, C.J., MacIntyre, A., Balin, B.J. and Appelt, D.M. ( 2004) Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB / c mice. Neurobiol Aging 25: 419-429.
47. Lycke, J., Malmestrom, C. and Stahle, L. ( 2003) Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir. Antimicrob Agents Chemother 47: 2438-2441.
48. Marques, A.R., Straus, S.E., Fahle, G., Weir, S., Csako, G. and Fischer, S.H. ( 2001) Lack of association between HSV-1 DNA in the brain, Alzheimer's disease and apolipoprotein E4. J Neurovirol 7: 82-83.
49. Marshall, B.J. and Warren, J.R. ( 1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311-1315.
50. Masci, S., de Simone, C., Famularo, G., Gravante, M., Ciancarelli, M., Andreassi, M. et al. (1995) Intravenous immunoglobulins suppress the recurrences of genital herpes simplex virus: a clinical and immunological study. Immunopharmacol Immunotoxicol 17: 33-47.
51. McQuaid, S., Allen, I.V., McMahon, J. and Kirk, J. ( 1994) Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis: a combined in situ hybridization and immunocytochemical investigation. Neuropathol Appl Neurobiol 20: 103-110.
52. Miklossy, J., Kis, A., Radenovic, A., Miller, L., Forro, L., Martins, R. et al. (2006) Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging 27: 228-236.
53. Miller, R.M. and Federoff, H.J. ( 2008) Isoform-specific effects of ApoE on HSV immediate early gene expression and establishment of latency. Neurobiol Aging 29: 71-77.
54. Mori, I., Kimura, Y., Naiki, H., Matsubara, R., Takeuchi, T., Yokochi, T. et al. (2004) Reactivation of HSV-1 in the brain of patients with familial Alzheimer's disease. J Med Virol 73: 605-611.
55. Pahnke, J., Walker, L.C., Scheffler, K. and Krohn, M. (2009) Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression? Neurosci Biobehav Rev 33: 1099-1108.
56. Pandey, J.P. ( 2009) Immunoglobulin GM genes as functional risk and protective factors for the development of Alzheimer's disease. J Alzheimers Dis 17: 753-756.
57. Relkin, N.R., Szabo, P., Adamiak, B., Burgut, T., Mon the, C., Lent, R.W. et al. (2009) 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease. Neurobiol Aging 30: 1728-1736.
58. Rodriguez, J.D., Royall, D., Daum, L.T., Kagan-Hallet, K. and Chambers, J.P. (2005) Amplification of Herpes simplex type 1 and Human Herpes type 5 viral DNA from formalin-fixed Alzheimer brain tissue. Neurosci Lett 390: 37-41.
59. Satpute-Krishnan, P., de Giorgis, J.A. and Bearer, E.L. ( 2003) Fast anterograde transport of herpes simplex virus: role for the amyloid precursor protein of Alzheimer's disease. Aging Cell 2: 305-318.
60. Skoldenberg, B., Kalimo, K., Carlstrom, A., Forsgren, M. and Halonen, P. ( 1981) Herpes simplex encephalitis: A serological follow-up study. Synthesis of herpes simplex virus immunoglobulin M, A, and G antibodies and development of oligoclonal immunoglobulin G in the central nervous system. Acta Neurol Scand 63: 273-285.
61. Soscia, S.J., Kirby, J.E., Washicosky, K.J., Tucker, S.M., Ingelsson, M., Hyman, B. et al. (2010) The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PloS ONE 5: e9505.
62. Stiles, K.M., Milne, R.S., Cohen, G.H., Eisenberg, R.J. and Krummenacher, C. ( 2008) The herpes simplex virus receptor nectin-1 is down-regulated after trans-interaction with glycoprotein D. Virology 373: 98-111.
63. Stowe, R.P., Kozlova, E.V., Yetman, D.L., Walling, D.M., Goodwin, J.S. and Glaser, R. ( 2007) Chronic herpesvirus reactivation occurs in aging. Exp Gerontol 42: 563-570.
64. Strandberg, T.E., Pitkala, K.H., Linnavuori, K.H. and Tilvis, R.S. ( 2003) Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke 34: 2126-2131.
65. Strobel, G. ( 2009) Prague: Aβ Rehabilitated as an Antimicrobial Protein? Alzheimer's Research Forum: http://www.alzforum.org/new/detail.asp?id=2090#{2923B2093D2096F-63782460B-2098C2053-443363B485284 }.
66. Tyler, K.L., Tedder, D.G., Yamamoto, L.J., Klapper, J.A., Ashley, R., Lichtenstein, K.A. et al. (1995) Recurrent brainstem encephalitis associated with herpes simplex virus type 1 DNA in cerebrospinal fluid. Neurology 45: 2246-2250.
67. Wojtowicz, W.M., Farzan, M., Joyal, J.L., Carter, K., Babcock, G.J., Israel, D.I. et al. (2002) Stimulation of enveloped virus infection by beta-amyloid fibrils. J Biol Chem 277: 35019-35024.
68. Wozniak, M.A., Faragher, E.B., Todd, J.A., Koram, K.A., Riley, E.M. and Itzhaki, R.F. ( 2003) Does apolipoprotein E polymorphism influence susceptibility to malaria? J Med Genet 40: 348-351.
69. Wozniak, M.A., Frost, A.L. and Itzhaki, R.F. (2009 a) Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis 16: 341-350.
70. Wozniak, M.A., Itzhaki, R.F., Faragher, E.B., James, M.W., Ryder, S.D. and Irving, W.L. ( 2002) Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Hepatology 36: 456-463.
71. Wozniak, M.A., Itzhaki, R.F., Shipley, S.J. and Dobson, C.B. ( 2007a) Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett 429: 95-100.
72. Wozniak, M.A., Mee, A.P. and Itzhaki, R.F. ( 2009b) Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. J Pathol 217: 131-138.
73. Wozniak, M.A., Shipley, S.J., Combrinck, M., Wilcock, G.K. and Itzhaki, R.F. ( 2005) Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients. J Med Virol 75: 300-306.
74. Wozniak, M.A., Shipley, S.J., Dobson, C.B., Parker, S.P., Scott, F.T., Leedham-Green, M. et al. (2007 b) Does apolipoprotein E determine outcome of infection by varicella zoster virus and by Epstein Barr virus? Eur J Hum Genet 15: 672-678.
75. WuDunn, D. and Spear, P.G. ( 1989) Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol 63: 52-58.
76. Zambrano, A., Solis, L., Salvadores, N., Cortes, M., Lerchundi, R. and Otth, C. ( 2008) Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1. J Alzheimers Dis 14: 259-269.